Biotia Leverages Genomics and AI to Provide Diagnostic Insights.
Diagnosing infectious disease is challenging, with a high rate of failure resulting in high mortality and alarming levels of drug resistance. Culturing, the current gold standard and technology from the 1800s, misses many important pathogens and requires many labor intensive tests. Even newer PCR-based tests are limited, problematic and don’t provide drug resistance information.
Working with hospitals internationally, we are leveraging next-generation DNA sequencing, and artificial intelligence, for rapid precision infectious disease diagnostics to guide patient treatment and improve health outcomes.